Join Inspira™ Technologies' Live Investor Webinar and Q&A Session on November 11

Core Insights - Inspira Technologies is hosting a webinar on November 11, 2024, to discuss its innovative life support technology [1][2] - The company has developed the INSPIRA™ ART, a device aimed at disrupting the $19 billion mechanical ventilation market by stabilizing blood oxygen levels without mechanical ventilation [2][4] - The INSPIRA™ ART is designed for patients with acute respiratory failure, allowing them to remain awake during treatment [4] Company Developments - The INSPIRA™ ART technology can elevate declining blood oxygen saturation levels in minutes, providing a potential alternative to traditional mechanical ventilators [2][4] - The device will be equipped with the HYLA™ blood sensor for real-time continuous blood monitoring, which alerts physicians to changes in a patient's condition [4] Market Potential - There are approximately 20 million intensive care unit patients with acute respiratory failure annually, many of whom currently rely on mechanical ventilators [4] - The innovative technology has the potential to significantly impact the mechanical ventilation market, which is valued at $19 billion [2][4]